Gimeno-Morales Marta, Motisi Laura, Rodriguez-Spiteri Natalia, Martínez-Regueira Fernando, Worthington Tucker, Therapist Radiation, Strnad Vratislav, Hannoun-Levi Jean Michel, Gutierrez Cristina
Department of Radiation Oncology, Cancer Center Clinica Universidad de Navarra, Pamplona, Spain.
Department of Radiation Oncology, Zürich University Hospital, Zürich, Switzerland.
J Contemp Brachytherapy. 2024 Feb;16(1):72-83. doi: 10.5114/jcb.2024.135635. Epub 2024 Feb 23.
Breast brachytherapy (BB) represents an important radiation therapy modality in modern breast cancer treatments. Currently, BB is mainly used for accelerated partial breast irradiation (APBI), local boost after whole breast radiation therapy (WBRT), and as salvage re-irradiation after second lumpectomy (APBrl). Two multi-catheter interstitial brachytherapy (MIB) techniques can be offered: intra-operative (IOB) and post-operative (POB) brachytherapy. The aim of this article was to summarize current available data on these two different brachytherapy approaches for breast cancer.
A literature search was performed, and different experiences published by BB expert teams were analyzed and compared. These two different brachytherapy approaches for breast cancer have also been presented and discussed during meetings of the GEC-ESTRO BCWG. In addition, expert recommendations were defined.
A comprehensive description and practical comparison of both the techniques, i.e., IOB and POB, considering the latest available published data were presented. Different technical, logistic, and clinical aspects of both the methods were thoroughly examined and analyzed. This detailed comparison of the two breast brachytherapy techniques was supported by scientific data from extensive experience of experts, facilitating an objective analysis that, to our knowledge, has not been previously published.
Based on the comprehensive analysis of both the brachytherapy techniques available, this article serves as a valuable resource to guide breast teams in selecting the optimal BB technique (POB or IOB), considering hospital environment, multi-disciplinary collaboration, and patient logistics.
乳腺近距离放射治疗(BB)是现代乳腺癌治疗中的一种重要放疗方式。目前,BB主要用于加速部分乳腺照射(APBI)、全乳放疗(WBRT)后的局部加量,以及作为二次保乳手术后的挽救性再照射(APBrl)。可提供两种多导管间质近距离放射治疗(MIB)技术:术中(IOB)和术后(POB)近距离放射治疗。本文的目的是总结目前关于这两种不同乳腺癌近距离放射治疗方法的可用数据。
进行文献检索,分析和比较BB专家团队发表的不同经验。在GEC-ESTRO BCWG会议期间,也介绍并讨论了这两种不同的乳腺癌近距离放射治疗方法。此外,还制定了专家建议。
结合最新发表的数据,对IOB和POB这两种技术进行了全面描述和实际比较。对这两种方法的不同技术、后勤和临床方面进行了深入研究和分析。来自专家丰富经验的科学数据支持了对这两种乳腺近距离放射治疗技术的详细比较,有助于进行据我们所知此前尚未发表的客观分析。
基于对现有两种近距离放射治疗技术的综合分析,本文可作为一份宝贵资源,指导乳腺治疗团队在考虑医院环境、多学科协作和患者后勤等因素的情况下,选择最佳的BB技术(POB或IOB)。